Listen to me, I will respond”: a randomized communication trial on vaccination decisions

Last registered on August 10, 2023
View Trial History

Pre-Trial

Trial Information

General Information

Title
Listen to me, I will respond”: a randomized communication trial on vaccination decisions
RCT ID
AEARCTR-0011862
Initial registration date
July 31, 2023

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
August 09, 2023, 2:48 PM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Last updated
August 10, 2023, 4:33 AM EDT

Last updated is the most recent time when changes to the trial's registration were published.

Locations

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Primary Investigator

Name
Alice Dominici
Affiliation
European University Institute, Department of Economics/Karolinska Institute, Department of Medical Epidemiology and Biostatistics
Contact Primary Investigator

Other Primary Investigator(s)

PI Name
Leonardo Boncinelli
PI Affiliation
University of Florence
Contact Investigator
PI Name
Ennio Bilancini
PI Affiliation
IMT Lucca
Contact Investigator
PI Name
Folco Panizza
PI Affiliation
IMT Lucca
Contact Investigator

Additional Trial Information

Status
In development
Start date
2023-09-15
End date
2024-07-31
Keywords
Health
Additional Keywords
JEL code(s)
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
We study whether motivational interviewing, a technique used in clinical dialogues, can foster vaccination uptake when applied in video informational campaigns. We investigate its interaction with more common nudges in a factorial design.
External Link(s)

Registration Citation

Citation
Bilancini, Ennio et al. 2023. "Listen to me, I will respond”: a randomized communication trial on vaccination decisions." AEA RCT Registry. August 10. https://doi.org/10.1257/rct.11862-1.1
Sponsors & Partners
Experimental Details

Interventions

Intervention(s)
Intervention Start Date
2023-09-15
Intervention End Date
2024-02-01

Primary Outcomes

Primary Outcomes (end points)
Self-reported intention to vaccinate right after treatment
Self-reported vaccination status against the flu 3-4 months after treatment
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
Listed in pre-analysis plan and visible in the attached surveys
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
Factorial: the combination of all 4 treatment creates 16 cells. For each one, we will invite approximately 500 subjects who will see the video and participate through an online survey.
Experimental Design Details
Not available
Randomization Method
Performed by the survey software upon connection
Randomization Unit
Individuals
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
None
Sample size: planned number of observations
12000
Sample size (or number of clusters) by treatment arms
500 in each of the 16 cells (the difference between the resulting sample size of 8000 and the overall planned number of observation of 12000 - the invitees) is to account for partial response rate.
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
Included in the attached pre-analysis plan
Supporting Documents and Materials

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information
IRB

Institutional Review Boards (IRBs)

IRB Name
European University Institute's Ethics Committee
IRB Approval Date
2023-07-28
IRB Approval Number
20220906_DOMINICI AMEND 1
Analysis Plan

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information